Carta Encíclica Laudato Si' de Santo Padre Francisco sobre el cuidado de la case común
Lettre Encyclique Laudato Si' du Saint-Père Francois sur la sauvegarde de la maison commune
Vatican lays out 20 points for a universal and fair destination of vaccines, for a fairer and healthier world
Studien der Sachverständigengruppe „Weltwirtschaft und Sozialethik“ Nr. 22
Eine interdisziplinäre Studie im Rahmen des Dialogprojektes zum weltkirchlichen Beitrag der katholischen Kirche für eine sozial-ökologische Transformation im Lichte von Laudato si'.
Indian J Palliat Care. 2011 Jan; 17(Suppl): S39–S41.
doi: 10.4103/0973-1075.76241
Dos & Don'ts for Volunteers: How to support refugees in a responsible and ethical manner
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan
...
demic laid this inequity bare, it also saw the pharmaceutical industry develop and bring new vaccines and treat- ments to market at unprecedented speed. As the world emerges from the worst
of this crisis, pharmaceutical companies are now at an important juncture, where lessons learned from the pandemic can prove pivotal in finding solutions to bridge long-standing gaps in access to medicine in LMICs.
more
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment
...
of five leading vaccine manufacturers, AstraZeneca plc, BioNTech SE, Johnson & Johnson, Moderna Inc., and Pfizer Inc. It also includes for the first time an assessment of the two largest Chinese vaccine producers, China National Pharmaceutical Group Co., Ltd. (Sinopharm) and Sinovac Biotech Ltd. (Sinovac).
more
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi
...
ve role in restricting fair access to a life-saving health product. This report focuses on six leading vaccine developers, AstraZeneca, BioNTech, Johnson & Johnson, Moderna, Novavax and Pfizer, assessing each company’s human rights policy, pricing structure, records on intellectual property, knowledge and technology sharing, allocation of available vaccine doses and transparency.
Available in Arabic, English, French, German and Spanish
more